Pulike Biological Engineering Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Pulike Biological Engineering has a total shareholder equity of CN¥2.6B and total debt of CN¥997.4K, which brings its debt-to-equity ratio to 0.04%. Its total assets and total liabilities are CN¥3.1B and CN¥451.6M respectively. Pulike Biological Engineering's EBIT is CN¥92.7M making its interest coverage ratio -21.6. It has cash and short-term investments of CN¥566.5M.
Belangrijke informatie
0.04%
Verhouding schuld/eigen vermogen
CN¥997.36k
Schuld
Rente dekkingsratio | -21.6x |
Contant | CN¥566.46m |
Aandelen | CN¥2.64b |
Totaal verplichtingen | CN¥451.59m |
Totaal activa | CN¥3.09b |
Recente financiële gezondheidsupdates
Recent updates
Pulike Biological Engineering's (SHSE:603566) Weak Earnings May Only Reveal A Part Of The Whole Picture
Sep 04Pulike Biological Engineering, Inc. (SHSE:603566) Looks Just Right With A 34% Price Jump
May 21Need To Know: The Consensus Just Cut Its Pulike Biological Engineering, Inc. (SHSE:603566) Estimates For 2024
Apr 28Why Investors Shouldn't Be Surprised By Pulike Biological Engineering, Inc.'s (SHSE:603566) Low P/E
Mar 21Pulike Biological Engineering (SHSE:603566) Seems To Use Debt Quite Sensibly
Feb 28Analyse van de financiële positie
Kortlopende schulden: 603566's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥411.3M).
Langlopende schulden: 603566's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥40.3M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 603566 has more cash than its total debt.
Schuld verminderen: 603566's debt to equity ratio has increased from 0% to 0.04% over the past 5 years.
Schuldendekking: 603566's debt is well covered by operating cash flow (22198.7%).
Rentedekking: 603566 earns more interest than it pays, so coverage of interest payments is not a concern.